The Safety and Efficacy of Redsenol-1 Plus on Cancer-related Fatigue in Adults

计划入组 72 人 · 首次发布于 2022 年 12 月 23 日

Efficacy and Safety of S-1 Plus Oxaliplatin in First-line Treatment of Ederly Patients With Advanced Gastric Cancer

计划入组 60 人 · 首次发布于 2021 年 1 月 5 日

Adjuvant Oxaliplatin Plus S-1 Versus Docetaxel Plus S-1 for Stage III Gastric Cancer

计划入组 387 人 · 首次发布于 2026 年 1 月 26 日

MonoGrippol plus

Grippol Plus

CanChew Plus

NHI-1

United States

OXYPROS PLUS

United States

Bumpers Plus

United States

Health Canada Clears Updated Clinical Trial Protocol for Redsenol-1 Plus

Camrelizumab Shows Promise in Initially Unresectable NSCLC

Golidocitinib Plus PD-1 Antibodies Shows Promise in NSCLC Patients After Anti-PD-1 Therapy Failure